Daphne Karydas - 13 Sep 2023 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Director
Signature
/s/ Adam Levy, Attorney-in-fact
Issuer symbol
MLYS
Transactions as of
13 Sep 2023
Net transactions value
$0
Form type
4
Filing time
14 Sep 2023, 16:13:53 UTC
Previous filing
17 Nov 2022
Next filing
20 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLYS Stock Option Award $0 +44,000 $0.000000 44,000 13 Sep 2023 Common Stock 44,000 $12.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in 36 monthly installments beginning on October 13, 2023.